首页 > 最新文献

Current Pain and Headache Reports最新文献

英文 中文
Focused Update on Migraine and Vertigo Comorbidity 偏头痛与眩晕并发症的最新进展
IF 3.7 2区 医学 Q1 Medicine Pub Date : 2024-04-18 DOI: 10.1007/s11916-024-01256-0
Tzu-Chou Huang, Qadeer Arshad, Amir Kheradmand

Purpose of Review

To provide an update on comorbidity of vestibular symptoms and migraine.

Recent Findings

Multisensory processing and integration is a key concept for understanding mixed presentation of migraine and vestibular symptoms. Here, we discuss how vestibular migraine should be distinguished from a secondary migraine phenomenon in which migraine symptoms may coincide with or triggered by another vestibular disorder. We also have some updates on the diagnostic criteria of vestibular migraine, its pathophysiology, and common approaches used for its treatment.

Summary

As a common clinical presentation of migraine and vestibular symptoms, vestibular migraine should be distinguished from a secondary migraine phenomenon, in which migraine symptoms may be triggered by or coincide with another vestibular disorder. Recent experimental evidence suggests vestibular symptoms in vestibular migraine are linked to multisensory mechanisms that control body motion and orientation in space.

最新研究结果多感觉处理和整合是理解偏头痛和前庭症状混合表现的一个关键概念。在此,我们讨论了如何将前庭性偏头痛与继发性偏头痛现象区分开来,继发性偏头痛现象是指偏头痛症状可能与另一种前庭疾病同时出现或由另一种前庭疾病引发。摘要 作为偏头痛和前庭症状的一种常见临床表现,前庭性偏头痛应与继发性偏头痛现象相区别,后者的偏头痛症状可能由另一种前庭疾病引发或与之同时出现。最近的实验证据表明,前庭性偏头痛的前庭症状与控制身体运动和空间定向的多感觉机制有关。
{"title":"Focused Update on Migraine and Vertigo Comorbidity","authors":"Tzu-Chou Huang, Qadeer Arshad, Amir Kheradmand","doi":"10.1007/s11916-024-01256-0","DOIUrl":"https://doi.org/10.1007/s11916-024-01256-0","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>To provide an update on comorbidity of vestibular symptoms and migraine.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>Multisensory processing and integration is a key concept for understanding mixed presentation of migraine and vestibular symptoms. Here, we discuss how vestibular migraine should be distinguished from a secondary migraine phenomenon in which migraine symptoms may coincide with or triggered by another vestibular disorder. We also have some updates on the diagnostic criteria of vestibular migraine, its pathophysiology, and common approaches used for its treatment.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>As a common clinical presentation of migraine and vestibular symptoms, vestibular migraine should be distinguished from a secondary migraine phenomenon, in which migraine symptoms may be triggered by or coincide with another vestibular disorder. Recent experimental evidence suggests vestibular symptoms in vestibular migraine are linked to multisensory mechanisms that control body motion and orientation in space.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140629543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Patient Education as Part of the Physiotherapy Management of Adults with Headache: A Scoping Review 作为成人头痛物理治疗一部分的患者治疗教育:范围审查
IF 3.7 2区 医学 Q1 Medicine Pub Date : 2024-04-13 DOI: 10.1007/s11916-024-01253-3
Sarah Mingels, Marita Granitzer, Kerstin Luedtke, Wim Dankaerts

Purpose of Review

Physiotherapy interventions for headache mostly include exercise and manual therapy. Yet, the complex nature of headache, sometimes characterized by symptoms of facilitated central pain mechanisms, demands an individualized approach in which therapeutic patient education could be supportive. This scoping review aimed to summarize the position of therapeutic patient education within the physiotherapy management of adults with headache. PubMed, EMBASE, Web of Science, and Scopus were searched. The search-query comprised terminology relating to “headache”, “education”, and “physiotherapy”. Eligibility criteria were: adults with headache, interventions including education within the domain of physiotherapy, reviews, clinical trials, cohort, case report, case–control studies.

Recent Findings

Eleven publications were included from the 281 retrieved publications. These publications were clinical trials (n = 4), reviews (n = 4), case-reports (n = 2), and a guideline (n = 1). Type of headaches studied were migraine (n = 3), post-traumatic headache (n = 2), tension-type headache (n = 2), cervicogenic headache (n = 1), primary headaches (n = 1), chronic daily headache (n = 1), and mixed migraine-cervicogenic headache (n = 1). Education seems an umbrella-term for postural education, lifestyle advice, and pain education. Three themes emerged across the publications: handling headache triggers (migraine, post-traumatic headache), promoting active lifestyle (post-traumatic headache, chronic daily headache, migraine), evaluating posture (post-traumatic headache, chronic daily headache, tension-type headache, cervicogenic headache). All publications recommended education in the management of headache. Only one (of the 11 included) publication described the educational program and determined its efficacy.

Summary

Based on this scoping review, therapeutic patient education seems supported within physiotherapy management of headache. However, it is unclear how such education is tailored to the specific needs of the individual, the headache subtype, or when it should be added to physiotherapy management of headache.

综述目的 头痛的物理治疗干预措施大多包括运动和手法治疗。然而,头痛的性质复杂,有时还伴有中枢疼痛机制紊乱的症状,因此需要采取个性化的治疗方法,而对患者的治疗教育可以起到辅助作用。本范围综述旨在总结治疗性患者教育在成人头痛物理治疗中的地位。我们检索了 PubMed、EMBASE、Web of Science 和 Scopus。搜索关键词包括 "头痛"、"教育 "和 "物理治疗"。资格标准为:患有头痛的成年人、包括物理治疗领域内的教育在内的干预措施、综述、临床试验、队列研究、病例报告、病例对照研究。这些出版物包括临床试验(4 篇)、综述(4 篇)、病例报告(2 篇)和指南(1 篇)。研究的头痛类型包括偏头痛(3 例)、创伤后头痛(2 例)、紧张型头痛(2 例)、颈源性头痛(1 例)、原发性头痛(1 例)、慢性日常头痛(1 例)和偏头痛-颈源性混合头痛(1 例)。教育似乎是姿势教育、生活方式建议和疼痛教育的总称。出版物中出现了三个主题:处理头痛诱因(偏头痛、创伤后头痛)、提倡积极的生活方式(创伤后头痛、慢性日常头痛、偏头痛)、评估姿势(创伤后头痛、慢性日常头痛、紧张型头痛、颈源性头痛)。所有出版物都建议开展头痛管理教育。小结根据本范围综述,在头痛的物理治疗管理中似乎支持对患者进行治疗性教育。然而,目前尚不清楚如何根据个人的具体需求和头痛亚型开展此类教育,也不清楚何时应在头痛物理治疗中加入此类教育。
{"title":"Therapeutic Patient Education as Part of the Physiotherapy Management of Adults with Headache: A Scoping Review","authors":"Sarah Mingels, Marita Granitzer, Kerstin Luedtke, Wim Dankaerts","doi":"10.1007/s11916-024-01253-3","DOIUrl":"https://doi.org/10.1007/s11916-024-01253-3","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>Physiotherapy interventions for headache mostly include exercise and manual therapy. Yet, the complex nature of headache, sometimes characterized by symptoms of facilitated central pain mechanisms, demands an individualized approach in which therapeutic patient education could be supportive. This scoping review aimed to summarize the position of therapeutic patient education within the physiotherapy management of adults with headache. PubMed, EMBASE, Web of Science, and Scopus were searched. The search-query comprised terminology relating to “headache”, “education”, and “physiotherapy”. Eligibility criteria were: adults with headache, interventions including education within the domain of physiotherapy, reviews, clinical trials, cohort, case report, case–control studies.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>Eleven publications were included from the 281 retrieved publications. These publications were clinical trials (<i>n</i> = 4), reviews (<i>n</i> = 4), case-reports (<i>n</i> = 2), and a guideline (<i>n</i> = 1). Type of headaches studied were migraine (<i>n</i> = 3), post-traumatic headache (<i>n</i> = 2), tension-type headache (<i>n</i> = 2), cervicogenic headache (<i>n</i> = 1), primary headaches (<i>n</i> = 1), chronic daily headache (<i>n</i> = 1), and mixed migraine-cervicogenic headache (<i>n</i> = 1). Education seems an umbrella-term for postural education, lifestyle advice, and pain education. Three themes emerged across the publications: handling headache triggers (migraine, post-traumatic headache), promoting active lifestyle (post-traumatic headache, chronic daily headache, migraine), evaluating posture (post-traumatic headache, chronic daily headache, tension-type headache, cervicogenic headache). All publications recommended education in the management of headache. Only one (of the 11 included) publication described the educational program and determined its efficacy.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>Based on this scoping review, therapeutic patient education seems supported within physiotherapy management of headache. However, it is unclear how such education is tailored to the specific needs of the individual, the headache subtype, or when it should be added to physiotherapy management of headache.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140569550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cannabinoids for Acute Pain Management: Approaches and Rationale 用于急性疼痛治疗的大麻素:方法与原理
IF 3.7 2区 医学 Q1 Medicine Pub Date : 2024-04-12 DOI: 10.1007/s11916-024-01252-4
Mihai O. Botea, Lukas Andereggen, Richard D. Urman, Markus M. Luedi, Carolina S. Romero

Purpose of the Review

Acute pain management remains a challenge and postoperative pain is often undermanaged despite many available treatment options, also including cannabinoids.

Recent Findings

In the light of the opioid epidemic, there has been growing interest in alternative care bundles for pain management, including cannabinoids as potential treatment to decrease opioid prescribing. Despite the lack of solid evidence on the efficacy of cannabinoids, their use among patients with pain, including those using opioids, is currently increasing. This use is supported by data suggesting that cannabinoids could potentially contribute to a better pain management and to a reduction in opioid doses while maintaining effective analgesia with minimum side effects.

Summary

The scientific basis for supporting the use of cannabis is extensive, although it does not necessarily translate into relevant clinical outcomes. The use of cannabinoids in acute pain did not always consistently show statistically significant results in improving acute pain. Large randomized, controlled trials evaluating diverse cannabis extracts are needed in different clinical pain populations to determine safety and efficacy.

近期研究结果鉴于阿片类药物的流行,人们对疼痛治疗的替代护理捆绑方案越来越感兴趣,其中包括大麻素作为减少阿片类药物处方的潜在治疗方法。尽管缺乏大麻素疗效的确凿证据,但目前疼痛患者(包括使用阿片类药物的患者)对大麻素的使用正在增加。支持使用大麻的数据表明,大麻素有可能有助于更好地控制疼痛和减少阿片类药物的剂量,同时保持有效镇痛并将副作用降至最低。在急性疼痛中使用大麻素在改善急性疼痛方面并不总能显示出具有统计学意义的显著效果。需要在不同的临床疼痛人群中进行大型随机对照试验,评估各种大麻提取物,以确定其安全性和有效性。
{"title":"Cannabinoids for Acute Pain Management: Approaches and Rationale","authors":"Mihai O. Botea, Lukas Andereggen, Richard D. Urman, Markus M. Luedi, Carolina S. Romero","doi":"10.1007/s11916-024-01252-4","DOIUrl":"https://doi.org/10.1007/s11916-024-01252-4","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of the Review</h3><p>Acute pain management remains a challenge and postoperative pain is often undermanaged despite many available treatment options, also including cannabinoids.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>In the light of the opioid epidemic, there has been growing interest in alternative care bundles for pain management, including cannabinoids as potential treatment to decrease opioid prescribing. Despite the lack of solid evidence on the efficacy of cannabinoids, their use among patients with pain, including those using opioids, is currently increasing. This use is supported by data suggesting that cannabinoids could potentially contribute to a better pain management and to a reduction in opioid doses while maintaining effective analgesia with minimum side effects.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>The scientific basis for supporting the use of cannabis is extensive, although it does not necessarily translate into relevant clinical outcomes. The use of cannabinoids in acute pain did not always consistently show statistically significant results in improving acute pain. Large randomized, controlled trials evaluating diverse cannabis extracts are needed in different clinical pain populations to determine safety and efficacy.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140570083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spinal Cord Stimulation Waveforms for the Treatment of Chronic Pain 用于治疗慢性疼痛的脊髓刺激波形
IF 3.7 2区 医学 Q1 Medicine Pub Date : 2024-04-12 DOI: 10.1007/s11916-024-01247-1
Ahish Chitneni, Esha Jain, Sidharth Sahni, Philippe Mavrocordatos, Alaa Abd-Elsayed

Purpose of Review

Since the advent of spinal cord stimulation (SCS), advances in technology have allowed for improvement and treatment of various conditions, especially chronic pain. Additionally, as the system has developed, the ability to provide different stimulation waveforms for patients to treat different conditions has improved. The purpose and objective of the paper is to discuss basics of waveforms and present the most up-to-date literature and research studies on the different types of waveforms that currently exist. During our literature search, we came across over sixty articles that discuss the various waveforms we intend to evaluate.

Recent Findings

There are several publications on several waveforms used in clinical practice, but to our knowledge, this is the only educational document teaching on waveforms which provides essential knowledge.

Summary

There is a gap of knowledge related to understanding wave forms and how they work.

综述目的自脊髓刺激(SCS)问世以来,技术的进步改善并治疗了各种病症,尤其是慢性疼痛。此外,随着系统的发展,为患者提供不同刺激波形以治疗不同病症的能力也得到了提高。本文的目的和目标是讨论波形的基础知识,并介绍有关现有不同类型波形的最新文献和研究。在文献检索过程中,我们发现有六十多篇文章讨论了我们打算评估的各种波形。最新研究结果有几篇出版物介绍了临床实践中使用的几种波形,但据我们所知,这是唯一一篇教授波形的教育文献,其中提供了基本知识。
{"title":"Spinal Cord Stimulation Waveforms for the Treatment of Chronic Pain","authors":"Ahish Chitneni, Esha Jain, Sidharth Sahni, Philippe Mavrocordatos, Alaa Abd-Elsayed","doi":"10.1007/s11916-024-01247-1","DOIUrl":"https://doi.org/10.1007/s11916-024-01247-1","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>Since the advent of spinal cord stimulation (SCS), advances in technology have allowed for improvement and treatment of various conditions, especially chronic pain. Additionally, as the system has developed, the ability to provide different stimulation waveforms for patients to treat different conditions has improved. The purpose and objective of the paper is to discuss basics of waveforms and present the most up-to-date literature and research studies on the different types of waveforms that currently exist. During our literature search, we came across over sixty articles that discuss the various waveforms we intend to evaluate.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>There are several publications on several waveforms used in clinical practice, but to our knowledge, this is the only educational document teaching on waveforms which provides essential knowledge.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>There is a gap of knowledge related to understanding wave forms and how they work.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140569444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virtual Reality in Acute and Chronic Pain Medicine: An Updated Review 急性和慢性疼痛医学中的虚拟现实技术:最新综述
IF 3.7 2区 医学 Q1 Medicine Pub Date : 2024-04-08 DOI: 10.1007/s11916-024-01246-2
Sacha Moreau, Alexandra Thérond, Ivo H. Cerda, Kachina Studer, Alicia Pan, Jacob Tharpe, Jason E. Crowther, Alaa Abd-Elsayed, Chris Gilligan, Reda Tolba, Sait Ashina, Michael E. Schatman, Alan D. Kaye, R. Jason Yong, Christopher L. Robinson

Purpose of Review

This review critically analyzes the recent literature on virtual reality’s (VR) use in acute and chronic pain management, offering insights into its efficacy, applications, and limitations.

Recent Findings

Recent studies, including meta-analyses and randomized controlled trials, have demonstrated VR’s effectiveness in reducing pain intensity in various acute pain scenarios, such as procedural/acute pain and in chronic pain conditions. The role of factors such as immersion and presence in enhancing VR’s efficacy has been emphasized. Further benefits have been identified in the use of VR for assessment as well as symptom gathering through conversational avatars. However, studies are limited, and strong conclusions will require further investigation.

Summary

VR is emerging as a promising non-pharmacological intervention in pain management for acute and chronic pain. However, its long-term efficacy, particularly in chronic pain management, remains an area requiring further research. Key findings highlight that VR programs vary in efficacy depending on the specificity of the origin of pain.

最近的研究结果最近的研究,包括荟萃分析和随机对照试验,都证明了虚拟现实技术在降低各种急性疼痛场景(如程序性疼痛/急性疼痛)和慢性疼痛条件下的疼痛强度方面的有效性。沉浸感和临场感等因素在增强 VR 疗效方面的作用得到了强调。通过会话化身将 VR 用于评估和症状收集方面的进一步优势已经得到确认。总结VR正逐渐成为治疗急性和慢性疼痛的非药物干预手段。然而,其长期疗效,尤其是在慢性疼痛治疗中的疗效,仍是一个需要进一步研究的领域。主要研究结果表明,VR 项目的疗效因疼痛起源的特异性而异。
{"title":"Virtual Reality in Acute and Chronic Pain Medicine: An Updated Review","authors":"Sacha Moreau, Alexandra Thérond, Ivo H. Cerda, Kachina Studer, Alicia Pan, Jacob Tharpe, Jason E. Crowther, Alaa Abd-Elsayed, Chris Gilligan, Reda Tolba, Sait Ashina, Michael E. Schatman, Alan D. Kaye, R. Jason Yong, Christopher L. Robinson","doi":"10.1007/s11916-024-01246-2","DOIUrl":"https://doi.org/10.1007/s11916-024-01246-2","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>This review critically analyzes the recent literature on virtual reality’s (VR) use in acute and chronic pain management, offering insights into its efficacy, applications, and limitations.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>Recent studies, including meta-analyses and randomized controlled trials, have demonstrated VR’s effectiveness in reducing pain intensity in various acute pain scenarios, such as procedural/acute pain and in chronic pain conditions. The role of factors such as immersion and presence in enhancing VR’s efficacy has been emphasized. Further benefits have been identified in the use of VR for assessment as well as symptom gathering through conversational avatars. However, studies are limited, and strong conclusions will require further investigation.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>VR is emerging as a promising non-pharmacological intervention in pain management for acute and chronic pain. However, its long-term efficacy, particularly in chronic pain management, remains an area requiring further research. Key findings highlight that VR programs vary in efficacy depending on the specificity of the origin of pain.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140569536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triptans in the Acute Migraine Management of Children and Adolescents: An Update 儿童和青少年急性偏头痛治疗中的 Triptans:最新进展
IF 3.7 2区 医学 Q1 Medicine Pub Date : 2024-04-06 DOI: 10.1007/s11916-024-01213-x

Abstract

Purpose of Review

To summarize recent findings regarding triptan use in the acute treatment of pediatric migraine.

Recent Findings

Prevalence of pediatric migraine is rising. The American Headache Society and American Academy of Neurology updated guidelines to provide evidence-based recommendations for the treatment of acute migraine in youth. In the setting of a dearth of new randomized controlled trials (RCTs), we review current guidelines, triptan use in the emergency department, and an era of secondary analyses.

Summary

Measuring the efficacy of triptans in pediatric migraine has been challenged by high placebo response rates. Secondary analyses, combining data from multiple RCTs, support that triptans are safe and effective in the treatment of migraine. Triptans are a vital tool and the only FDA-approved migraine-specific treatment available in pediatrics. There is a need for further studies and funding support in pediatric headache medicine.

摘要 综述目的 总结有关在急性期治疗小儿偏头痛时使用三苯氧胺的最新研究结果。 最新发现 小儿偏头痛的发病率正在上升。美国头痛学会和美国神经病学会更新了指南,为治疗青少年急性偏头痛提供了循证建议。在缺乏新的随机对照试验(RCT)的情况下,我们回顾了当前的指南、急诊科使用三苯氧胺的情况以及二次分析的时代。 摘要 衡量三苯氧胺对小儿偏头痛的疗效一直受到高安慰剂反应率的挑战。综合多项临床试验数据进行的二次分析表明,三苯氧胺对治疗偏头痛安全有效。三苯氧胺是一种重要的治疗工具,也是目前唯一获得美国食品及药物管理局批准的儿科偏头痛特效治疗药物。儿科头痛医学需要进一步的研究和资金支持。
{"title":"Triptans in the Acute Migraine Management of Children and Adolescents: An Update","authors":"","doi":"10.1007/s11916-024-01213-x","DOIUrl":"https://doi.org/10.1007/s11916-024-01213-x","url":null,"abstract":"<h3>Abstract</h3> <span> <h3>Purpose of Review</h3> <p>To summarize recent findings regarding triptan use in the acute treatment of pediatric migraine.</p> </span> <span> <h3>Recent Findings</h3> <p>Prevalence of pediatric migraine is rising. The American Headache Society and American Academy of Neurology updated guidelines to provide evidence-based recommendations for the treatment of acute migraine in youth. In the setting of a dearth of new randomized controlled trials (RCTs), we review current guidelines, triptan use in the emergency department, and an era of secondary analyses.</p> </span> <span> <h3>Summary</h3> <p>Measuring the efficacy of triptans in pediatric migraine has been challenged by high placebo response rates. Secondary analyses, combining data from multiple RCTs, support that triptans are safe and effective in the treatment of migraine. Triptans are a vital tool and the only FDA-approved migraine-specific treatment available in pediatrics. There is a need for further studies and funding support in pediatric headache medicine.</p> </span>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140569446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Idiopathic Intracranial Hypertension After Abrupt Cessation of Medication: A Case Report of Abrupt Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Cessation and Review of the Literature 突然停药后的特发性颅内高压:胰高血糖素样肽-1(GLP-1)受体激动剂突然停药的病例报告和文献综述
IF 3.7 2区 医学 Q1 Medicine Pub Date : 2024-04-04 DOI: 10.1007/s11916-024-01215-9
Brittany Heckel

Purpose of Review

The purpose of this review is two-fold: (1) to discuss a case report of idiopathic intracranial hypertension (IIH) after abrupt cessation of a glucagon-like peptide-1 (GLP-1) receptor agonist with resultant rapid weight gain and (2) to review the literature regarding the potential role of GLP-1 receptor agonists in the treatment of IIH as well as potential pitfalls.

Recent Findings

GLP-1 receptor agonists have become widely used to treat obesity. Obesity is a known risk factor for the development of IIH, though the precise pathophysiology is unclear. GLP-1 receptor agonists may help treat IIH by promoting weight loss, lipolysis of adipose tissue, and potentially decreasing the secretion of CSF, as was seen in rat models. Abrupt cessation of GLP-1 receptor agonists can result in regaining lost weight rapidly. In the case that we present, the patient stopped duraglutide abruptly due to lack of insurance coverage and regained the weight she had lost within a month. She subsequently developed IIH.

Summary

GLP-1 receptor agonists have the potential to help treat IIH; however, this class of medication needs to be used carefully, as cessation of the medication and resultant rapid weight gain can result in IIH.

综述目的本综述有两个目的:(1) 讨论一例在突然停用胰高血糖素样肽-1 (GLP-1) 受体激动剂后导致体重迅速增加的特发性颅内高压 (IIH) 病例报告;(2) 综述有关 GLP-1 受体激动剂在 IIH 治疗中的潜在作用以及潜在隐患的文献。虽然确切的病理生理学尚不清楚,但肥胖是IIH发病的一个已知风险因素。GLP-1 受体激动剂可促进体重减轻、脂肪组织脂肪分解,并有可能减少 CSF 的分泌,从而有助于治疗 IIH,这一点在大鼠模型中也有所体现。突然停用 GLP-1 受体激动剂会导致失去的体重迅速恢复。在我们介绍的病例中,患者由于没有保险而突然停用度拉鲁肽,结果在一个月内体重又恢复了。小结GLP-1受体激动剂有可能有助于治疗IIH;但是,这类药物需要谨慎使用,因为停药后体重迅速增加可能导致IIH。
{"title":"Idiopathic Intracranial Hypertension After Abrupt Cessation of Medication: A Case Report of Abrupt Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Cessation and Review of the Literature","authors":"Brittany Heckel","doi":"10.1007/s11916-024-01215-9","DOIUrl":"https://doi.org/10.1007/s11916-024-01215-9","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>The purpose of this review is two-fold: (1) to discuss a case report of idiopathic intracranial hypertension (IIH) after abrupt cessation of a glucagon-like peptide-1 (GLP-1) receptor agonist with resultant rapid weight gain and (2) to review the literature regarding the potential role of GLP-1 receptor agonists in the treatment of IIH as well as potential pitfalls.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>GLP-1 receptor agonists have become widely used to treat obesity. Obesity is a known risk factor for the development of IIH, though the precise pathophysiology is unclear. GLP-1 receptor agonists may help treat IIH by promoting weight loss, lipolysis of adipose tissue, and potentially decreasing the secretion of CSF, as was seen in rat models. Abrupt cessation of GLP-1 receptor agonists can result in regaining lost weight rapidly. In the case that we present, the patient stopped duraglutide abruptly due to lack of insurance coverage and regained the weight she had lost within a month. She subsequently developed IIH.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>GLP-1 receptor agonists have the potential to help treat IIH; however, this class of medication needs to be used carefully, as cessation of the medication and resultant rapid weight gain can result in IIH.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140569534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infrapatellar Branch of the Saphenous Nerve: Therapeutic Approaches to Chronic Knee Pain. 隐神经髌下分支:慢性膝关节疼痛的治疗方法。
IF 3.7 2区 医学 Q1 Medicine Pub Date : 2024-04-01 Epub Date: 2024-01-31 DOI: 10.1007/s11916-024-01217-7
Alaa Abd-Elsayed, Lukas J Henjum, Barnabas T Shiferaw, Peter E Yassa, Kenneth J Fiala

Purpose of review: The infrapatellar branch of the saphenous nerve (IPS) is an under-investigated nerve that can be a source of chronic knee pain. This literature review aims to deliver an up-to-date review of chronic pain transmitted via the IPS along with therapeutic approaches available for pain refractory to conservative measures.

Recent findings: Knee pain transmitted via the IPS can arise from several etiologies. Damage to the IPS is often iatrogenic and develops following total knee arthroplasty, anterior cruciate ligament reconstruction, and other knee surgical procedures. Other causes of IPS-derived pain include entrapment of the nerve, neuromas, Schwannomas, and pain from knee osteoarthritis transmitted through the IPS.This article investigated therapeutic approaches to pain derived from the IPS. Common approaches included radiofrequency ablation, neuroma excisions, Schwannoma excision, nerve blocks, surgical exploration, surgical release of an entrapped nerve, cryoablation, and peripheral nerve stimulation. Pain scores, duration of pain relief, adverse events, and secondary outcomes were all included in this review. A subset of the patient population experiences chronic pain deriving from the IPS that is refractory to conservative treatment measures. This review aims to evaluate the etiologies and therapeutic approaches for chronic pain arising from the IPS refractory to conservative treatments.

审查目的:隐神经髌下支(IPS)是一种未得到充分研究的神经,可能是慢性膝关节疼痛的来源。这篇文献综述旨在对通过 IPS 传导的慢性疼痛进行最新综述,并介绍对保守治疗无效的疼痛可采用的治疗方法:通过 IPS 传播的膝关节疼痛可由多种病因引起。IPS 的损伤通常是先天性的,在全膝关节置换术、前交叉韧带重建术和其他膝关节外科手术后出现。导致 IPS 疼痛的其他原因包括神经卡压、神经瘤、许万瘤以及通过 IPS 传播的膝关节骨关节炎引起的疼痛。常见的方法包括射频消融、神经瘤切除、许万瘤切除、神经阻滞、手术探查、手术松解卡压神经、冷冻消融和周围神经刺激。疼痛评分、疼痛缓解持续时间、不良事件和次要结果均包括在本综述中。有一部分患者因 IPS 引起的慢性疼痛而无法接受保守治疗。本综述旨在评估对保守治疗无效的 IPS 引起的慢性疼痛的病因和治疗方法。
{"title":"Infrapatellar Branch of the Saphenous Nerve: Therapeutic Approaches to Chronic Knee Pain.","authors":"Alaa Abd-Elsayed, Lukas J Henjum, Barnabas T Shiferaw, Peter E Yassa, Kenneth J Fiala","doi":"10.1007/s11916-024-01217-7","DOIUrl":"10.1007/s11916-024-01217-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>The infrapatellar branch of the saphenous nerve (IPS) is an under-investigated nerve that can be a source of chronic knee pain. This literature review aims to deliver an up-to-date review of chronic pain transmitted via the IPS along with therapeutic approaches available for pain refractory to conservative measures.</p><p><strong>Recent findings: </strong>Knee pain transmitted via the IPS can arise from several etiologies. Damage to the IPS is often iatrogenic and develops following total knee arthroplasty, anterior cruciate ligament reconstruction, and other knee surgical procedures. Other causes of IPS-derived pain include entrapment of the nerve, neuromas, Schwannomas, and pain from knee osteoarthritis transmitted through the IPS.This article investigated therapeutic approaches to pain derived from the IPS. Common approaches included radiofrequency ablation, neuroma excisions, Schwannoma excision, nerve blocks, surgical exploration, surgical release of an entrapped nerve, cryoablation, and peripheral nerve stimulation. Pain scores, duration of pain relief, adverse events, and secondary outcomes were all included in this review. A subset of the patient population experiences chronic pain deriving from the IPS that is refractory to conservative treatment measures. This review aims to evaluate the etiologies and therapeutic approaches for chronic pain arising from the IPS refractory to conservative treatments.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139643266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of Repetitive Transcranial Magnetic Stimulation for Chronic Daily Headache Prophylaxis: A Systematic Review and Meta-Analysis. 重复经颅磁刺激对慢性日常头痛预防的效用:系统回顾与元分析》。
IF 3.2 2区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-04-01 Epub Date: 2024-01-26 DOI: 10.1007/s11916-024-01210-0
Emily Stephens, Chathurika S Dhanasekara, Victor Montalvan, Bei Zhang, Ashley Bassett, Rebecca Hall, Alyssa Rodaniche, Christina Robohm-Leavitt, Chwan-Li Shen, Chanaka N Kahatuduwa

Purpose of review: Management of chronic daily headaches (CDH) remains challenging due to the limited efficacy of standard prophylactic pharmacological measures. Several studies have reported that repetitive transcranial magnetic stimulation (rTMS) can effectively treat chronic headaches. The objective was to determine the utility of rTMS for immediate post-treatment and sustained CDH prophylaxis.

Recent findings: All procedures were conducted per PRISMA guidelines. PubMed, Scopus, Web of Science, and ProQuest databases were searched for controlled clinical trials that have tested the efficacy of rTMS on populations with CDH. DerSimonian-Laird random-effects meta-analyses were performed using the 'meta' package in R to examine the post- vs. pre-rTMS changes in standardized headache intensity and frequency compared to sham-control conditions. Thirteen trials were included with a combined study population of N = 538 patients with CDH (rTMS, N = 284; Sham, N = 254). Patients exposed to rTMS had significantly reduced standardized CDH intensity and frequency in the immediate post-treatment period (Hedges' g = -1.16 [-1.89, -0.43], p = 0.002 and Δ = -5.07 [-10.05, -0.11], p = 0.045 respectively). However, these effects were sustained marginally in the follow-up period (Hedges' g = -0.43 [-0.76, -0.09], p = 0.012 and Δ = -3.33 [-5.52, -1.14], p = 0.003). Significant between-study heterogeneity was observed, at least partially driven by variations in rTMS protocols. Despite the observed clinically meaningful and statistically significant benefits in the immediate post-treatment period, the prophylactic effects of rTMS on CDH do not seem to sustain with discontinuation. Thus, the cost-effectiveness of the routine use of rTMS for CDH prophylaxis remains questionable.

Registration: Protocol preregistered in PROSPERO International Prospective Register of Systematic Reviews (CRD42021250100).

综述目的:由于标准预防性药物治疗的疗效有限,慢性日常头痛(CDH)的治疗仍具有挑战性。一些研究报告称,重复经颅磁刺激(rTMS)可有效治疗慢性头痛。该研究旨在确定经颅磁刺激在治疗后立即和持续预防 CDH 方面的效用:所有程序均按照 PRISMA 指南进行。我们在 PubMed、Scopus、Web of Science 和 ProQuest 数据库中搜索了测试经颅磁刺激对 CDH 患者疗效的对照临床试验。使用 R 中的 "meta "软件包进行了 DerSimonian-Laird 随机效应荟萃分析,以检验经颅磁刺激后与经颅磁刺激前相比,假对照条件下标准化头痛强度和频率的变化。共纳入了 13 项试验,研究对象包括 N = 538 名 CDH 患者(经颅磁刺激,N = 284;假对照,N = 254)。接受经颅磁刺激治疗的患者在治疗后的一段时间内,CDH的标准化强度和频率明显降低(Hedges' g = -1.16 [-1.89, -0.43],p = 0.002;Δ = -5.07 [-10.05, -0.11],p = 0.045)。然而,这些影响在随访期间略有持续(Hedges' g = -0.43 [-0.76, -0.09], p = 0.012 和 Δ = -3.33 [-5.52, -1.14], p = 0.003)。研究之间存在显著的异质性,至少部分原因是经颅磁刺激方案的不同。尽管在治疗后短期内观察到了具有临床意义和统计学意义的疗效,但经颅磁刺激对 CDH 的预防效果似乎并不会随着治疗的中断而持续。因此,常规使用经颅磁刺激对 CDH 进行预防的成本效益仍然值得怀疑:协议已在 PROSPERO 国际系统综述前瞻性注册中心(CRD42021250100)注册。
{"title":"Utility of Repetitive Transcranial Magnetic Stimulation for Chronic Daily Headache Prophylaxis: A Systematic Review and Meta-Analysis.","authors":"Emily Stephens, Chathurika S Dhanasekara, Victor Montalvan, Bei Zhang, Ashley Bassett, Rebecca Hall, Alyssa Rodaniche, Christina Robohm-Leavitt, Chwan-Li Shen, Chanaka N Kahatuduwa","doi":"10.1007/s11916-024-01210-0","DOIUrl":"10.1007/s11916-024-01210-0","url":null,"abstract":"<p><strong>Purpose of review: </strong>Management of chronic daily headaches (CDH) remains challenging due to the limited efficacy of standard prophylactic pharmacological measures. Several studies have reported that repetitive transcranial magnetic stimulation (rTMS) can effectively treat chronic headaches. The objective was to determine the utility of rTMS for immediate post-treatment and sustained CDH prophylaxis.</p><p><strong>Recent findings: </strong>All procedures were conducted per PRISMA guidelines. PubMed, Scopus, Web of Science, and ProQuest databases were searched for controlled clinical trials that have tested the efficacy of rTMS on populations with CDH. DerSimonian-Laird random-effects meta-analyses were performed using the 'meta' package in R to examine the post- vs. pre-rTMS changes in standardized headache intensity and frequency compared to sham-control conditions. Thirteen trials were included with a combined study population of N = 538 patients with CDH (rTMS, N = 284; Sham, N = 254). Patients exposed to rTMS had significantly reduced standardized CDH intensity and frequency in the immediate post-treatment period (Hedges' g = -1.16 [-1.89, -0.43], p = 0.002 and Δ = -5.07 [-10.05, -0.11], p = 0.045 respectively). However, these effects were sustained marginally in the follow-up period (Hedges' g = -0.43 [-0.76, -0.09], p = 0.012 and Δ = -3.33 [-5.52, -1.14], p = 0.003). Significant between-study heterogeneity was observed, at least partially driven by variations in rTMS protocols. Despite the observed clinically meaningful and statistically significant benefits in the immediate post-treatment period, the prophylactic effects of rTMS on CDH do not seem to sustain with discontinuation. Thus, the cost-effectiveness of the routine use of rTMS for CDH prophylaxis remains questionable.</p><p><strong>Registration: </strong>Protocol preregistered in PROSPERO International Prospective Register of Systematic Reviews (CRD42021250100).</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139562626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical Spinal Cord Stimulation: A Review. 颈椎脊髓刺激:综述。
IF 3.7 2区 医学 Q1 Medicine Pub Date : 2024-04-01 Epub Date: 2023-12-26 DOI: 10.1007/s11916-023-01200-8
Lucky Krog, Jillian Maloney, Scott Pew, Olufunmilola Adeleye, Brooks Johnson, Brett Glenn, Benjamin Gill, Vinicius Tieppo Francio, Robert Pagan-Rosado, Madeline Whitney, Neil Sinha, Natalie Strand

Purpose of review: This literature review critically examines existing studies on cervical spinal cord stimulation (cSCS) for the treatment of chronic pain. The objective is to evaluate the current evidence, identify knowledge gaps, and collate data to inform clinical decision-making and suggest future research avenues. The review covers indications, contraindications, surgical and anesthetic approaches, trials, efficacy, and complications of cSCS.

Recent findings: Recent advancements highlight the evolving role of cSCS in chronic pain management. New neuromodulation techniques involve optimal placement of leads based on the pain's innervation level, maximizing therapeutic outcomes. Contemporary studies underscore the broadening benefits of cSCS, including enhanced functional abilities and sleep quality. However, alongside these innovations come challenges; emerging data bring attention to complications such as hardware issues and infections. Significantly, modern research emphasizes the crucial role of accurate patient selection, factoring in prior therapy responses and comprehensive evaluations. cSCS emerges as a promising tool for chronic pain management, with benefits beyond mere pain relief. As surgical techniques, patient selection criteria, and postoperative care refine, the potential of cSCS expands to benefit a broader patient demographic. However, further comprehensive research is necessary to enhance its application, validate its role earlier in treatment, and ultimately ameliorate the lives of those with chronic pain.

综述目的:本文献综述严格审查了有关颈脊髓刺激(cSCS)治疗慢性疼痛的现有研究。目的是评估现有证据,找出知识差距,整理数据,为临床决策提供依据,并提出未来的研究方向。综述内容包括 cSCS 的适应症、禁忌症、手术和麻醉方法、试验、疗效和并发症:最新研究结果:最新进展凸显了 cSCS 在慢性疼痛治疗中不断发展的作用。新的神经调控技术包括根据疼痛的神经支配水平优化导联的放置,从而最大限度地提高治疗效果。当代研究强调了 cSCS 带来的更多益处,包括增强功能能力和提高睡眠质量。然而,这些创新也带来了挑战;新出现的数据引起了人们对硬件问题和感染等并发症的关注。值得注意的是,现代研究强调了准确选择患者的关键作用,并将之前的治疗反应和综合评估考虑在内。随着手术技术、患者选择标准和术后护理的不断完善,cSCS 的潜力将不断扩大,使更多患者受益。然而,还需要进一步的综合研究来加强其应用,验证其在早期治疗中的作用,并最终改善慢性疼痛患者的生活。
{"title":"Cervical Spinal Cord Stimulation: A Review.","authors":"Lucky Krog, Jillian Maloney, Scott Pew, Olufunmilola Adeleye, Brooks Johnson, Brett Glenn, Benjamin Gill, Vinicius Tieppo Francio, Robert Pagan-Rosado, Madeline Whitney, Neil Sinha, Natalie Strand","doi":"10.1007/s11916-023-01200-8","DOIUrl":"10.1007/s11916-023-01200-8","url":null,"abstract":"<p><strong>Purpose of review: </strong>This literature review critically examines existing studies on cervical spinal cord stimulation (cSCS) for the treatment of chronic pain. The objective is to evaluate the current evidence, identify knowledge gaps, and collate data to inform clinical decision-making and suggest future research avenues. The review covers indications, contraindications, surgical and anesthetic approaches, trials, efficacy, and complications of cSCS.</p><p><strong>Recent findings: </strong>Recent advancements highlight the evolving role of cSCS in chronic pain management. New neuromodulation techniques involve optimal placement of leads based on the pain's innervation level, maximizing therapeutic outcomes. Contemporary studies underscore the broadening benefits of cSCS, including enhanced functional abilities and sleep quality. However, alongside these innovations come challenges; emerging data bring attention to complications such as hardware issues and infections. Significantly, modern research emphasizes the crucial role of accurate patient selection, factoring in prior therapy responses and comprehensive evaluations. cSCS emerges as a promising tool for chronic pain management, with benefits beyond mere pain relief. As surgical techniques, patient selection criteria, and postoperative care refine, the potential of cSCS expands to benefit a broader patient demographic. However, further comprehensive research is necessary to enhance its application, validate its role earlier in treatment, and ultimately ameliorate the lives of those with chronic pain.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139038174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Pain and Headache Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1